Clinical Trials Browser

Phase 2 × Burkitt Lymphoma × Interleukin 1 Receptor Antagonist Protein × Clear all

NCT04148430 2025-11-05

A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy

Phase 2 Active not recruiting

Burkitt Lymphoma, Lymphoma, B-Cell